Omadacycline

CHEMBL1689772 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
556.6 g/mol
LogP
3.0
Phase
4

A tetracycline-class antibiotic used to treat community-acquired bacterial pneumonia and acute skin and skin structure infections caused by susceptible organisms. It is active against many multidrug-resistant bacteria including MRSA and atypical pathogens.

Molecular Weight

556.6000 g/mol

LogP

3.00

TPSA

177.00 Ų

Lipinski RO5

Fail

Therapeutic Areas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)c1cc(CNCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O

InChI

InChI=1S/C29H40N4O7/c1-28(2,3)12-31-11-14-10-17(32(4)5)15-8-13-9-16-21(33(6)7)24(36)20(27(30)39)26(38)29(16,40)25(37)18(13)23(35)19(15)22(14)34/h10,13,16,21,31,34,36-37,40H,8-9,11-12H2,1-7H3,(H2,30,39)/t13-,16-,21-,29-/m0/s1

Molecular Formula

C29H40N4O7

HBD / HBA

6 / 10

Rotatable Bonds

7

Heavy Atoms

40

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A tetracycline-class antibiotic used to treat community-acquired bacterial pneumonia and acute skin and skin structure infections caused by susceptible organisms. It is active against many multidrug-resistant bacteria including MRSA and atypical pathogens.

Yes, Omadacycline is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1689772. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 54697325. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.